CTI BioPharma Corp (CTIC)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Adam R. Craig
Employees:
120
3101 WESTERN AVENUE, SUITE 800, SEATTLE, WA, 98121
2062827100
-
Formally known as:
- Cell Therapeutics, Inc.
Date | Ratio |
---|---|
2007-04-16 | 1:4 |
2008-09-02 | 1:1 |
2011-05-16 | 1:6 |
2012-09-04 | 1:5 |
2017-01-03 | 1:10 |
CTI BioPharma Corp. focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|